Eur J Gastroenterol Hepatol
September 2014
Background: It has been suggested that GastroPanel might be a useful tool for the diagnosis of chronic atrophic gastritis (CAG) measuring four biomarkers in blood: basal gastrin-17 (G17), pepsinogen I and II (PGI and PGII), and Helicobacter pylori antibodies.
Aim: To determine the accuracy of GastroPanel for the diagnosis of CAG.
Methods: This was a prospective, blinded, multicenter study that included dyspeptic patients.